The REDUCE-IT Trial: A New Hope for Heart Health – Premier Catch
Marine n−3 Fatty Acids and Prevention of Cardiovascular Disease and Cancer | NEJM
Contrasting results of REDUCE-IT and STRENGTH trials of Omega 3 – All About Cardiovascular System and Disorders
CardsJC: STRENGTH Trial Journal Club - Cardionerds
Cardiovascular, electrophysiologic, and hematologic effects of omega-3 fatty acids beyond reducing hypertriglyceridemia: as it pertains to the recently published REDUCE-IT trial | Cardiovascular Diabetology | Full Text
Update on the omega-3 fatty acid trial landscape: A narrative review with implications for primary prevention - Journal of Clinical Lipidology
New trial data show mixed findings for omega-3s
Cardiovascular Risk Reduction with Icosapent Ethyl for Hypertriglyceridemia | NEJM
Results of STRENGTH Trial with Omega-3 Fatty Acids Question Validity of REDUCE-It Trial | Pri-Med
Sultania Cardiovascular Sciences - Ascend- Omega 3 Trial.. Among diabetic patients with no known CVD, omega-3 fatty acid supplementation was not beneficial. Omega-3 fatty acids failed to reduce the incidence of major
REDUCE-IT Trial: Reduction of Cardiovascular Events with Icosapent Ethyl–Intervention Trial | tctmd.com
Flow chart of participants in the Omega-3 to Reduce the Incidence of... | Download Scientific Diagram
A Fishy Topic: VITAL, REDUCE-IT, STRENGTH, and Beyond: Putting Omega-3 Fatty Acids into Practice in 2021 | SpringerLink
Mechanistic Insights from REDUCE-IT STRENGTHen the Case Against Triglyceride Lowering as a Strategy for Cardiovascular Disease Risk Reduction - ScienceDirect
Fishing for Links Between Omega-3 Fatty Acids and Atrial Fibrillation | Circulation
Omega-3 Icosapent Ethyl and Stroke Reduction in Atherosclerotic Vascular Disease - YouTube
Omega-3s Support Heart Health in Healthy People (VITAL: Vitamin D and Omega-3 Trial)
IJMS | Free Full-Text | Omega-3 Polyunsaturated Fatty Acids—Vascular and Cardiac Effects on the Cellular and Molecular Level (Narrative Review)
Two Landmark Studies Shed New Light-and Shadow- on Omega-3s for CVD - Holistic Primary Care
Study design for REDUCE-IT. | Download Scientific Diagram
REDUCE-IT (Vascepa) vs. STRENGTH (Epanova)- Why the Different Results? - NutritionHeart.com
Emerging Mechanisms of Cardiovascular Protection for the Omega-3 Fatty Acid Eicosapentaenoic Acid | Arteriosclerosis, Thrombosis, and Vascular Biology
IJMS | Free Full-Text | Omega-3 Fatty Acids and Neurodegenerative Diseases: New Evidence in Clinical Trials
Does omega-3 reduce cardiovascular disease? Comparing major trials REDUCE IT, VITAL, and STRENGTH
Nutrients | Free Full-Text | Beneficial Outcomes of Omega-6 and Omega-3 Polyunsaturated Fatty Acids on Human Health: An Update for 2021
